Clinical impact of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial.
cardiac surgery
del Nido cardioplegia
myocardial protection
Journal
The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
18
05
2021
revised:
09
01
2022
accepted:
23
01
2022
medline:
1
11
2023
pubmed:
14
3
2022
entrez:
13
3
2022
Statut:
ppublish
Résumé
The study objective was to assess the benefits of del Nido cardioplegia compared with cold blood cardioplegia solution in terms of myocardial protection during adult cardiac surgery. A total of 474 adult patients undergoing coronary artery bypass grafting, heart valve surgery, thoracic aortic surgery, or combined procedures were randomized to the del Nido cardioplegia group (n = 234) or the cold blood cardioplegia solution group (n = 240) after provided informed consent. The primary end points assessed inotropic support requirements, severe cardiovascular events, and troponin trend within the first 48 hours of intensive care unit stay. Reperfusion arrhythmias, aortic crossclamp and cardiopulmonary bypass times, and other clinical perioperative variables were considered as secondary end points. No statistically significant differences were found regarding postoperative inotropic support requirements or the incidence of severe cardiovascular events. The del Nido cardioplegia group showed a higher return to spontaneous sinus rhythm (P< .001), a lower number of defibrillation attempts (P< .001), and an earlier peak troponin value in the postoperative period. Peak blood glucose levels and intravenous insulin requirements were significantly lower in the del Nido cardioplegia group. We found no significant differences regarding aortic crossclamp or cardiopulmonary bypass time. We did observe a lower incidence of postoperative stroke in the del Nido cardioplegia group (2.6% vs 6.7%; P= .035). del Nido cardioplegia can be used safely and with comparable outcomes compared with traditional cardioplegia solutions. Additional advantages over glycemic control, reperfusion arrhythmias, and its comfortable redosing interval make del Nido an interesting alternative for myocardial protection in adult cardiac surgery. A significant decrease in postoperative stroke will require further research to shed light on the results of this study. VIDEO ABSTRACT.
Identifiants
pubmed: 35279289
pii: S0022-5223(22)00123-4
doi: 10.1016/j.jtcvs.2022.01.044
pii:
doi:
Substances chimiques
Cardioplegic Solutions
0
Troponin
0
Banques de données
ClinicalTrials.gov
['NCT04094168']
Types de publication
Randomized Controlled Trial
Video-Audio Media
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1458-1467Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.